Speaker illustration

Doctor Jose Pablo Werba

Monzino Cardiology Centre, Milan (Italy)

Pablo Werba is a specialist in Internal Medicine. In the early 90' he trained as a lipidologist in the Institute of Pharmacological Sciencies and the E. Grossi Paoletti Center for the study of dyslipidaemias. University of Milano, Italy. Between 2002 and 2012 he directed a Lipid Clinic and a Laboratory for animal studies in atherosclerosis in the Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation. Buenos Aires, Argentina. Since 2002 he is the head of the Unit of Atherosclerosis Prevention in the Cardiologic Monzino Center, IRCCS, in Milan, Italy. His main activities are related to the diagnosis and management of vascular risk factors and to clinical research in lipidology, cardiovascular prevention and pathogenesis of atherosclerosis. He published 60 papers in peer-reviewed journals (in lipidology and CV prevention). Impact factor mean: 4,2. median: 3,5; H index: 18; total citations: 1092 (scopus 12-2-2019) and 4 chapters in books.

Taking part in a structured long-term secondary prevention program significantly limits event recurrence after coronary artery bypass surgery: a five year follow-up

Event: EuroPrevent 2019

Topic: Secondary Prevention

Session: Rapid Fire Session 2

Thumbnail

Early adopters of a free-access cardiovascular prevention program in a multiethnic community in north Italy

Event: ESC Congress 2016

Topic: Psycho-social, economic, cultural, occupational diseases

Session: Improving support for patients with cardiovascular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb